Dose–Response Efficacy of a Proprietary Probiotic Formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for Antibiotic-Associated Diarrhea and Clostridium difficile-Associated Diarrhea Prophylaxis in Adult Patients

The mechanisms and efficacy of probiotics in the prevention of Clostridium difficile-associated diarrhoea

(2009) Gareth C Parkes et al.   LANCET INFECTIOUS DISEASES

The Use of Probiotics in the Prevention and Treatment of Antibiotic-Associated Diarrhea With Special Interest in Clostridium difficile–Associated Diarrhea

(2009) Cynthia L. Rohde et al.   NUTRITION IN CLINICAL PRACTICE

Both Oral Metronidazole and Oral Vancomycin Promote Persistent Overgrowth of Vancomycin-Resistant Enterococci during Treatment of Clostridium difficile-Associated Disease

(2008) W. N. Al-Nassir et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparison of Clinical and Microbiological Response to Treatment ofClostridium difficile–Associated Disease with Metronidazole and Vancomycin

(2008) Wafa N. Al‐Nassir et al.   CLINICAL INFECTIOUS DISEASES

Probiotics as prevention and treatment for diarrhea

(2008) Alfredo Guarino et al.   CURRENT OPINION IN GASTROENTEROLOGY

Antibiotic-associated diarrhea: epidemiology, trends and treatment

(2008) Lynne V McFarland   Future Microbiology

Probiotics for Prevention of Antibiotic-associated Diarrhea

(2008) Shira Idit Doron et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Meta-analysis of probiotics for the treatment of irritable bowel syndrome

(2008) Lynne V McFarland et al.   WORLD JOURNAL OF GASTROENTEROLOGY